Yisheng Pharmaceutical (002566.SZ) announced first-quarter results, net profit of 21.64 million yuan, a decrease of 26.78%
Yisheng Pharmaceutical (002566.SZ) released its report for the first quarter of 2024, achieving revenue of 200 million yuan during the reporting period...
Yisheng Pharmaceutical (002566.SZ): As of April 19, 2024, the total number of shareholders of the company was 23,879
Gelonghui, April 24 | Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that as of April 19, 2024, the total number of shareholders of the company was 23,879.
Express News | Yisheng Pharmaceutical: Net profit of 94.732 million yuan in 2023 increased 14.00% year-on-year, and plans to pay 10 to 1.5 yuan
The A-share Chinese medicine sector fluctuated and boosted, and Dali Pharmaceutical rose and stopped out of the 8-game chain
Gelonghui, March 21 | Dali Pharmaceutical broke out of the 8-game losing streak, while Yisheng Pharmaceutical, Xinguang Pharmaceutical, Tailong Pharmaceutical, and Longjin Pharmaceutical rallied.
Jian Yisheng Pharma Sets Up 3 Million Yuan Subsidiary
Jilin Jian Yisheng Pharmaceutical (SHE:002566) established and registered a new subsidiary with a registered capital of 3 million yuan in Hangzhou, Zhejiang Province, China, according to a Wednesday f
Yisheng Pharmaceutical (002566.SZ): The subsidiary Han Shen Cosmetics has health food products that are lightweight and prolong the age
Gelonghui, Feb. 29丨Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that the company has no weight loss medications, and that its subsidiary Hansen Cosmetics has health food products to keep the body healthy and prolong the age.
Yisheng Pharmaceutical (002566.SZ): The company's traditional Chinese medicine injections include intravenous injections, etc.
Gelonghui, Feb. 29丨Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that the company's traditional Chinese medicine injections include intravenous injections, Qingkailing injections, compound musk injections, Xiangdan injections, etc.
Yisheng Pharmaceutical (002566.SZ): As of January 31, the total number of shareholders of the company was 24,444
On February 2, Gelonghui Pharmaceutical (002566.SZ) said on the investor interactive platform that as of January 31, the total number of shareholders of the company was 24,444.
Yisheng Pharmaceutical (002566.SZ): The company and China Perfect have not cooperated
On January 23, Gelonghui | Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that the company and China have not cooperated.
Yisheng Pharmaceutical (002566.SZ): The total number of shareholders of the company as of January 19 was 24,765
Gelonghui January 22丨Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that as of January 19, the total number of shareholders of the company was 24,765.
Yisheng Pharmaceutical (002566.SZ): Has a variety of ginseng series health foods
Gelonghui, January 11丨An investor asked Yisheng Pharmaceutical (002566.SZ) on the investor interactive platform, “Red ginseng drinks are selling very well in Korea, and people are gradually drinking them domestically. Is the company considering developing corresponding ginseng health drinks?” The company replied that the company has a variety of ginseng health foods, such as red ginseng wheat dong cream, red ginseng extract concentrate, Airun, and Dayang Hero.
A-share traditional Chinese medicine stocks fluctuated and rose, and Bio Valley rose more than 7%
Gelonghui, January 9 | Biogu rose more than 7%, Yisheng Pharmaceutical rose more than 5%, and Dali Pharmaceutical, Xinguang Pharmaceutical, Guizhou Sanli, and Panlong Pharmaceutical followed suit.
Yisheng Pharmaceutical (002566.SZ): The company's cosmetics business is currently mainly facing the domestic market
Gelonghui, January 8 | Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that the company's cosmetics business is currently mainly facing the domestic market.
Yisheng Pharmaceutical (002566.SZ): Received a total of 10.356 million yuan in government subsidies
On December 15, Gelonghui Pharmaceutical (002566.SZ) announced that the company and its subsidiaries have received a total of RMB 10.356 million in government subsidies from February 21, 2023 to the date of disclosure of the announcement, including government subsidies of RMB 3.356 million relating to revenue and RMB 700,000 million in asset-related government subsidies.
Yisheng Pharmaceutical (002566.SZ): Up to now, the area of local ginseng is more than 2,400 mu
Gelonghui, December 12|Yisheng Pharmaceutical (002566.SZ) said on the investor interactive platform that up to now, the area of local ginseng is more than 2,400 mu.
Yisheng Pharmaceutical (002566.SZ): The company's inventory is mainly ginseng inventory
Gelonghui December 12|Yisheng Pharmaceutical (002566.SZ) Investor Interactive Platform stated that the company's inventory is mainly ginseng inventory. For details of the inventory categories, please refer to the 2022 Annual Report.
Yisheng Pharmaceutical (002566.SZ): The main business does not involve medical devices or medical equipment
Gelonghui December 12丨Yisheng Pharmaceutical (002566.SZ) stated on the investor interactive platform that the company's main business is the production and sale of Chinese and Western pharmaceutical preparations, and does not involve medical devices or medical equipment.
Yisheng Pharmaceutical (002566.SZ): There are drugs used for mycoplasma pneumonia, such as erythromycin enteric tablets
On December 8, Gelonghui, some investors asked Yisheng Pharmaceutical (002566.SZ) on the investor interactive platform, “Mycoplasma broke out across the country! May I ask if your company makes better preventive medicines!” The company replied that the company has drugs used for mycoplasma pneumonia, such as erythromycin enteric tablets, as well as drugs used to treat colds and coughs.
Yisheng Pharmaceutical (002566.SZ): Currently, the company's pharmaceuticals have not yet launched export business
On December 7, Gelonghui, some investors asked Yisheng Pharmaceutical (002566.SZ) on the investor interactive platform, “Which countries and regions does the company's pharmaceutical production mainly export to?” The company replied that at present, the company's pharmaceuticals have not yet been exported.
Yisheng Pharmaceutical (002566.SZ): Product erythromycin enteric tablets can be used to treat mycoplasma pneumonia and chlamydia pneumonia
Gelonghui, December 6|Yisheng Pharmaceutical (002566.SZ) stated on the investor interactive platform that the company's product, erythromycin enteric tablets, can be used to treat mycoplasma pneumonia and chlamydia pneumonia.
No Data